Skip to main content

Advertisement

SpringerLink
Log in

Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry

  • Peritoneal Surface Malignancy
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Well-differentiated papillary mesothelioma of the peritoneum (WDPMP) is a rare entity. Questions regarding management are still being debated as no more than 50 cases have been reported in the literature.

Objective

We aimed to analyze the clinical, therapeutic, and prognostic data of patients with WDPMP from the RENAPE observational registry.

Patients and Methods

All patients diagnosed with WDPMP and prospectively included in the RENAPE national registry between 2010 and 2018 were also included in our study. Expert pathologists from the RENA-PATH group confirmed all cases. All clinical, therapeutic, postoperative, and prognostic data were extracted and analyzed.

Results

We report on 56 patients with a mean age of 52 years (range 21–74). WDPMP was incidentally diagnosed during imaging or surgery in 16% and 36% of patients, respectively, and an association with synchronous malignancy was found in 18% of patients. Nine lesions showed discrete signs of fatty invasion. The median Peritoneal Cancer Index was 11 (range 0–33). Eleven patients were treated with definitive excision, 4 were treated with cytoreductive surgery (CRS) only, 37 were treated with CRS and hyperthermic intraperitoneal chemotherapy (HIPEC), and 2 were treated with CRS plus HIPEC plus early postoperative intraperitoneal chemotherapy. CRS was considered to be complete in 90% of cases. One patient died postoperatively and 16 patients (31%) faced postoperative complications. The median disease-free survival was 144 months; Four patients relapsed, with a median period of 27 months. No prognostic factors could be identified.

Conclusions

Our analysis confirms the favorable prognosis of WDPMP. CRS and HIPEC could be a therapeutic option for diffuse, symptomatic, and/or recurrent disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18(6):985–90.

    Article  CAS  Google Scholar 

  2. de Pangher Manzini V. Malignant peritoneal mesothelioma. Tumori. 2005;91(1):1–5.

    Google Scholar 

  3. Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer. 2013;49(15):3140–8.

    Article  Google Scholar 

  4. Hejmadi R, Ganesan R, Kamal NG. Malignant transformation of a well-differentiated peritoneal papillary mesothelioma. Acta Cytol. 2003;47(3):517–8.

    PubMed  Google Scholar 

  5. Burrig KF, Pfitzer P, Hort W. Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol. 1990;417(5):443–7.

  6. Malpica A, Sant’Ambrogio S, Deavers MT, Silva EG. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012;36(1):117–27.

    Article  Google Scholar 

  7. Shinozaki-Ushiku A, Ushiku T, Morita S, Anraku M, Nakajima J, Fukayama M. Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma. Histopathology. 2017;70(5):722–33.

    Article  Google Scholar 

  8. Stevers M, Rabban JT, Garg K, Van Ziffle J, Onodera C, Grenert JP, et al. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Mod Pathol. 2019;32(1):88–99.

    Article  CAS  Google Scholar 

  9. Lee YK, Jun HJ, Nahm JH, Lim TS, Park JS, Ahn JB, et al. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. Jpn J Clin Oncol. 2013;43(10):996–1003.

    Article  Google Scholar 

  10. Bazine A, Fetohi M, Namad T, Benzekri A, Zainoun B, Tanz R, et al. A case of well-differentiated papillary mesothelioma of the male peritoneum: successful treatment by systemic chemotherapy. Cureus. 2017;9(3):e1104.

    PubMed  PubMed Central  Google Scholar 

  11. Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol. 2007;14(10):2790–7.

    Article  CAS  Google Scholar 

  12. Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, et al. The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists [in French]. Ann Pathol. 2014;34(1):4–8.

  13. Villeneuve L, Passot G, Glehen O, Isaac S, Bibeau F, Rousset P, et al. The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis. 2017;12(1):37.

    Article  CAS  Google Scholar 

  14. Galateau-Salle F, Gilg Soit Ilg A, Le Stang N, Brochard P, Pairon JC, Astoul P, et al. The French mesothelioma network from 1998 to 2013 [in French]. Ann Pathol. 2014;34(1):51–63.

  15. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res. 2007;134:247–64.

    CAS  PubMed  Google Scholar 

  16. Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin North Am. 2003;12(3):703–27, xiii.

  17. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res. 1996;82:235–53.

    Article  CAS  Google Scholar 

  18. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.

    Article  CAS  Google Scholar 

  19. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal carcinomatosis: principles of management. Cancer treatment and research, EJ Freireich Series editors. Boston: Kluwer Academic Publishers; 1996. p. 359–74.

  20. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon’s role. Langenbecks Arch Surg. 1999;384(6):576–87.

    Article  CAS  Google Scholar 

  21. Brigand C, Monneuse O, Mohamed F, Sayag-Beaujard AC, Isaac S, Gilly FN, et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006;13(3):405–12.

    Article  CAS  Google Scholar 

  22. Yan TD, Welch L, Black D, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol. 2007;18(5):827–34.

    Article  CAS  Google Scholar 

  23. Kepenekian V, Elias D, Passot G, Mery E, Goere D, Delroeux D, et al. Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study. Eur J Cancer. 2016;65:69–79.

    Article  CAS  Google Scholar 

  24. National Cancer Institute PROCSG. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 2010 [updated 14 June 2010]. http://evs.nci.nih.gov/ftp1/CTCAE/About.html.

  25. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018.

  26. Nasit JG, Dhruva G. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology. Am J Clin Pathol. 2014;142(2):233–42.

    Article  Google Scholar 

  27. Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol. 2001;25(10):1304–9.

    Article  CAS  Google Scholar 

  28. Daya D, McCaughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer. 1990;65(2):292–6.

  29. Deraco M, Nizri E, Glehen O, Baratti D, Tuech JJ, Bereder JM, et al. Well differentiated papillary peritoneal mesothelioma treated by cytoreduction and hyperthermic intraperitoneal chemotherapy-the experience of the PSOGI registry. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2018.10.065

  30. Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Salle F, Hwang H, et al. Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014;38(7):990–8.

    Article  Google Scholar 

  31. Washimi K, Yokose T, Amitani Y, Nakamura M, Osanai S, Noda H, et al. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report. Pathol Int. 2013;63(4):220–5.

    Article  Google Scholar 

  32. Jatzko GR, Jester J. Simultaneous occurrence of a rectal carcinoma and a diffuse well differentiated papillary mesothelioma of the peritoneum. Int J Colorectal Dis. 1997;12(6):326–8.

    Article  CAS  Google Scholar 

  33. Gill SE, Ruple SM, Wolff CM, Puls LE. Simultaneous occurrence of well differentiated papillary mesothelioma and endometrioid ovarian cancer: a case report. Gynecol Oncol Case Rep. 2013;4:53–5.

    Article  Google Scholar 

  34. Rathi V, Hyde S, Newman M. Well-differentiated papillary mesothelioma in association with endometrial carcinoma: a case report. Acta Cytol. 2010;54(5 Suppl):793–7.

    PubMed  Google Scholar 

  35. Irwin GW, Ervine A, Kennedy JA. Well-differentiated papillary mesothelioma: peritoneal implants are not always metastases in the presence of cancer. Scott Med J. 2014;59(1):e18–21.

    Article  CAS  Google Scholar 

  36. Erkanli S, Kilicdag EB, Bolat F, Kayaselcuk F, Bagis T, Haberal A, et al. Well-differentiated papillary mesothelioma complicating endometrial carcinoma: a case report. Eur J Gynaecol Oncol. 2004;25(3):394–6.

    CAS  PubMed  Google Scholar 

  37. Chen X, Sheng W, Wang J. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology. 2013;62(5):805–13.

    Article  Google Scholar 

  38. Hoekstra AV, Riben MW, Frumovitz M, Liu J, Ramirez PT. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98(1):161–7.

    Article  Google Scholar 

Download references

Acknowledgment

The collaborators of the RENAPE Network include: Julio Abba, MD (Department of Digestive Surgery, Grenoble University Hospital, Grenoble, France); Karine Abboud, MD (Department of General Surgery, CHU Hospital, Jean Monnet University, Saint Étienne, France); Mohammad Alyami, MD (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Catherine Arvieux, MD, PhD (Department of Digestive Surgery, Grenoble University Hospital, Grenoble, France); Gerlinde Averous, MD (Department of Pathology, Hautepierre University Hospital, Strasbourg, France); Naoual Bakrin, MD, PhD (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Houda Ben Rejeb, MD (Department of Pathology, Bergonie Institute, Bordeaux, France); Nazim Benzerdjeb, MD, PhD (Department of Pathology, Lyon-Sud University Hospital, Lyon, France); Isabelle Berton-Rigaud (Department of Digestive Oncology, ICO René Gauducheau Cancer Center, Saint-Herblain, France); Frédéric Bibeau, MD, PhD (Department of Pathology, Côte de Nacre University Hospital, Caen, France); Isabelle Bonnefoy (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Dominique Bouzard, MD (Department of Surgery, Louis Mourier University Hospital, Colombes, France); Cécile Brigand, MD, PhD (Department of Digestive Surgery, Hautepierre University Hospital, Strasbourg, France); Sébastien Carrère, MD (Department of Surgical Oncology, Val d’Aurelle Montpellier Cancer Center, Montpellier, France); Anne Chevallier, MD (Department of Pathology, Archet 2 University Hospital, Nice, France); Virginie Cloud (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Thomas Courvoisier, MD (Department of Digestive Surgery, Poitiers University Hospital, Poitiers, France); Jean-Baptiste Delhorme, MD, PhD (Department of Digestive Surgery, Hautepierre University Hospital, Strasbourg, France); Anthony Dohan, MD, PhD (Department of Radiology, Lariboisière University Hospital, Paris, France); Frédéric Dumont (Department of Surgical Oncology, ICO René Gauducheau Cancer Center, Saint-Herblain, France); Clarisse Eveno, MD, PhD (Surgical Oncologic and Digestive Unit, Lariboisière University Hospital, Paris, France); Juliette Fontaine, MD (Department of Pathology, Lyon-Sud University Hospital, Lyon, France); Johan Gagniere, MD (Department of Digestive Surgery, Estaing University Hospital, Clermont-Ferrand, France); Laurent Ghouti, MD (Department of Digestive Surgery, Purpan University Hospital, Toulouse, France); François-Noël Gilly, MD, PhD (Department of Digestive Surgery, Centre Hospitalier Lyon Sud, Pierre-Bénite, France); Laurence Gladieff, MD (Department of Medical Oncology, Claudius Regaud Institute IUTC, Toulouse, France); Jean-Marc Guilloit, MD (Department of Surgical Oncology, Francois Baclesse Comprehensive Cancer Center, Caen, France); Frédéric Guyon, MD (Department of Surgical Oncology, Bergonie Institute, Bordeaux, France); Sylvie Isaac, MD (Department of Pathology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France, France); Peggy Jourdan-Enfer (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Rachid Kaci, MD (Department of Pathology, Lariboisière University Hospital, Paris, France); Reza Kianmanesh (Department of Digestive Surgery, Robert Debré University Hospital, Reims, France); Marie-Hélène Laverrière, MD (Department of Pathology, Grenoble University Hospital, Grenoble, France); Bernard Lelong, MD (Department of Surgical Oncology, Paoli Calmettes Institute, Marseille, France); Agnès Leroux-Broussier, MD (Department of Pathology, Lorraine Institute of Oncology, Vandoeuvre-les-Nancy, France); Réa Lo Dico, MD, PhD (Surgical Oncologic and Digestive Unit, Lariboisière University Hospital, Paris, France); Gérard Lorimier, MD (Department of Digestive Surgery, Angers University Hospital, Angers, France); Pascale Mariani, MD (Department of Surgical Oncology, Curie Institute, Paris, France); Emilie Mathiotte (Hospices Civils de Lyon, Pôle de Santé Publique, Unité de Recherche Clinique, Lyon, France); Pierre Meeus, MD (Department of Surgery, Léon Bérard Comprehensive Cancer Center, Lyon, France); Eliane Mery, MD (Department of Pathology, Claudius Regaud Institute IUTC, Toulouse, France); Simon Msika, MD, PhD (Department of Surgery, Louis Mourier University Hospital, Colombes, France); Cédric Nadeau, MD (Gynaecology and Obstetrics Ward, Mother and Child Pole, Poitiers University Hospital, University of Poitiers, Poitiers, France); Pablo Ortega-Deballon, MD, PhD (Department of Digestive Surgical Oncology, University Hospital of Dijon, Dijon, France); Brice Paquette, MD (Department of Digestive Surgery, Minjoz University Hospital, Besançon, France); Guillaume Passot, MD, PhD, (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Olivier Pellet, MD (INOLA, Lyon, France); Patrice Peyrat, MD (Department of Surgery, Léon Bérard Comprehensive Cancer Center, Lyon, France); Denis Pezet, MD, PhD (Department of Digestive Surgery, Estaing University Hospital, Clermont-Ferrand, France); Nicolas Pirro, MD, PhD (Department of Digestive Surgery, Timône University Hospital, Marseille, France); Marc Pocard, MD, PhD (Surgical Oncologic and Digestive Unit, Lariboisière University Hospital, Paris, France); Flora Poizat, MD (Department of Pathology, Paoli Calmettes Institute, Marseille, France); Jack Porcheron, MD, PhD (Department of Digestive Surgery, St Etienne University Hospital, St Etienne, France); François Quenet, MD (Department of Digestive Surgical Oncology, Montpellier Cancer Institute, Montpellier, France); Patrick Rat, MD, PhD (Department of Digestive Surgical Oncology, University Hospital of Dijon, Dijon, France); Pierre Rousselot, MD (Department of Pathology, Francois Baclesse Comprehensive Cancer Center, Caen, France); Pascal Rousset, MD, PhD, (Department of Radiology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France); Hélène Senellart (Department of Medical Oncology, ICO René Gauducheau Cancer Center, Saint-Herblain, France); Martine Serrano (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Olivia Sgarbura, MD (Department of Surgical Oncology, Val d’Aurelle Montpellier Cancer Center, Montpellier, France); Magali Svrcek, MD, PhD (Department of Pathology, Hospital Saint-Antoine AP-HP, Paris, France); Emilie Thibaudeau, MD (Department of Surgical Oncology, ICO René Gauducheau Cancer Center, Saint-Herblain, France); Yann Touchefeu (Department of Gastroenterology, Nantes University Hospital, Nantes, France); Séverine Valmary-Degano, MD, PhD (Department of Pathology, Minjoz University Hospital, Besançon, France); Delphine Vaudoyer, MD (Department of Digestive Surgery, Lyon-Sud University Hospital, Lyon, France); Véronique Verriele-Beurrier, MD (Department of Pathology, ICO Paul Papin Cancer Center, Angers, France); Romuald Wernert, MD (Department of Surgical Oncology, ICO Paul Papin Cancer Center, Angers, France); Franck Zinzindohoue, MD, PhD (Department of Digestive and General Surgery, G. Pompidou European Hospital, Paris, France).

Funding

RENAPE is funded by the French National Cancer Institute (INCa).

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, France

    Guillaume Vogin MD, PhD

  2. UMR 7365 CNRS-Université de Lorraine, IMoPA, Vandoeuvre-les-Nancy, France

    Guillaume Vogin MD, PhD & Liza Hettal MSc

  3. Department of Pathology, Centre Hospitalier Universitaire de Nancy, Vandoeuvre-les-Nancy, France

    Jean-Michel Vignaud MD, PhD

  4. Department of Pathology, Gustave Roussy Institute, Villejuif, France

    Peggy Dartigues MD

  5. Department of Surgery, Gustave Roussy Institute, Villejuif, France

    Diane Goere MD, PhD

  6. Department of Surgical Oncology, Institut Universitaire du Cancer de Toulouse – Oncopole, Toulouse, France

    Gwenaël Ferron MD, PhD

  7. Department of Surgical Oncology, Jean Minjoz University Hospital, Besançon, France

    Bruno Heyd MD, PhD

  8. Department of Surgical Oncology, L’Archet II University Hospital, Nice, France

    Jean-Marc Bereder MD

  9. Department of Surgical Oncology, Charles Nicolles University Hospital, Rouen, France

    Jean-Jacques Tuech MD, PhD

  10. Department of Digestive Surgery, Centre Hospitalier Lyon Sud, Pierre-Bénite, France

    Olivier Glehen MD, PhD & Vahan Kepenekian MD

  11. Department of Surgical Oncology, Paoli Calmettes Institute, Marseille, France

    Cécile de Chaisemartin MD

  12. RENAPE, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France

    Olivier Glehen MD, PhD, Yoann Lherm MSc & Laurent Villeneuve PhD

  13. Unité de Recherche Clinique, Pôle de Santé Publique, Hospices Civils de Lyon, Pierre-Bénite, France

    Yoann Lherm MSc & Laurent Villeneuve PhD

  14. EMR 3738, Lyon 1 University, Lyon, France

    Olivier Glehen MD, PhD & Laurent Villeneuve PhD

  15. Department of Surgery, Institut de Cancérologie de Lorraine, Vandoeuvre-les-Nancy, France

    Frédéric Marchal MD, PhD

  16. UMR 7039, CNRS-Université de Lorraine, CRAN, Vandoeuvre-les-Nancy, France

    Frédéric Marchal MD, PhD

Authors
  1. Guillaume Vogin MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liza Hettal MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Michel Vignaud MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peggy Dartigues MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diane Goere MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gwenaël Ferron MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bruno Heyd MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-Marc Bereder MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean-Jacques Tuech MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Olivier Glehen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Cécile de Chaisemartin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yoann Lherm MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Laurent Villeneuve PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Vahan Kepenekian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Frédéric Marchal MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the RENAPE Network

  • Julio Abba MD
  • , Karine Abboud MD
  • , Mohammad Alyami MD
  • , Catherine Arvieux MD, PhD
  • , Gerlinde Averous MD
  • , Naoual Bakrin MD, PhD
  • , Houda Ben Rejeb MD
  • , Nazim Benzerdjeb MD, PhD
  • , Isabelle Berton-Rigaud
  • , Frédéric Bibeau MD, PhD
  • , Isabelle Bonnefoy
  • , Dominique Bouzard MD
  • , Cécile Brigand MD, PhD
  • , Sébastien Carrère MD
  • , Anne Chevallier MD
  • , Virginie Cloud
  • , Thomas Courvoisier MD
  • , Jean-Baptiste Delhorme MD, PhD
  • , Anthony Dohan MD, PhD
  • , Frédéric Dumont
  • , Clarisse Eveno MD, PhD
  • , Juliette Fontaine MD
  • , Johan Gagniere MD
  • , Laurent Ghouti MD
  • , François-Noël Gilly MD, PhD
  • , Laurence Gladieff MD
  • , Jean-Marc Guilloit MD
  • , Frédéric Guyon MD
  • , Sylvie Isaac MD
  • , Peggy Jourdan-Enfer
  • , Rachid Kaci MD
  • , Reza Kianmanesh
  • , Marie-Hélène Laverrière MD
  • , Bernard Lelong MD
  • , Agnès Leroux-Broussier MD
  • , Réa Lo Dico MD, PhD
  • , Gérard Lorimier MD
  • , Pascale Mariani MD
  • , Emilie Mathiotte
  • , Pierre Meeus MD
  • , Eliane Mery MD
  • , Simon Msika MD, PhD
  • , Cédric Nadeau MD
  • , Pablo Ortega-Deballon MD, PhD
  • , Brice Paquette MD
  • , Guillaume Passot MD, PhD
  • , Olivier Pellet MD
  • , Patrice Peyrat MD
  • , Denis Pezet MD, PhD
  • , Nicolas Pirro MD, PhD
  • , Marc Pocard MD, PhD
  • , Flora Poizat MD
  • , Jack Porcheron MD, PhD
  • , François Quenet MD
  • , Patrick Rat MD, PhD
  • , Pierre Rousselot MD
  • , Pascal Rousset MD, PhD
  • , Hélène Senellart
  • , Martine Serrano
  • , Olivia Sgarbura MD
  • , Magali Svrcek MD, PhD
  • , Emilie Thibaudeau MD
  • , Yann Touchefeu
  • , Séverine Valmary-Degano MD, PhD
  • , Delphine Vaudoyer MD
  • , Véronique Verriele-Beurrier MD
  • , Romuald Wernert MD
  •  & Franck Zinzindohoue MD, PhD

Contributions

Guillaume Vogin: Original draft, writing, and data interpretation. Liza Hettal: Data analysis and interpretation, review and editing. Jean-Michel Vignaud: Review and editing (pathology). Peggy Dartigues: Data acquisition, review and editing. Diane Goere: Data acquisition, review and editing. Gwenaël Ferron: Data acquisition, review and editing. Bruno Heyd: Data acquisition, review and editing. Jean-Marc Bereder: Data acquisition, review and editing. Jean-Jacques Tuech: Data acquisition, review and editing. Vahan Kepenekian: Data acquisition, review and editing. Cécile de Chaisemartin: Data acquisition, review and editing. Yoann Lherm: Data management, quality control of data, review and editing. Laurent Villeneuve: Project administration, review and editing. Olivier Glehen: Funding acquisition, review and editing. Frédéric Marchal: Study design, review and editing.

Corresponding author

Correspondence to Guillaume Vogin MD, PhD.

Ethics declarations

DISCLOSURE

There is no conflict of interest to disclose from any authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vogin, G., Hettal, L., Vignaud, JM. et al. Well-Differentiated Papillary Mesothelioma of the Peritoneum: A Retrospective Study from the RENAPE Observational Registry. Ann Surg Oncol 26, 852–860 (2019). https://doi.org/10.1245/s10434-018-07153-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-07153-2

Search

Navigation